Ramdevbaba Solvent Limited (NSE:RBS)
India · Delayed Price · Currency is INR 90.00
-2.00 (-2.17%)
Feb 13, 2026, 3:17 PM IST
Ramdevbaba Solvent Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 9,126 | 9,287 | 6,864 | 6,978 | 5,829 | 4,239 |
Other Revenue | 1.61 | 1.61 | 1.8 | 3.34 | 5.55 | 4.07 |
| 9,127 | 9,288 | 6,866 | 6,981 | 5,834 | 4,243 | |
Revenue Growth (YoY) | 15.01% | 35.28% | -1.64% | 19.65% | 37.49% | 21.62% |
Cost of Revenue | 7,760 | 7,962 | 5,674 | 5,889 | 4,878 | 3,424 |
Gross Profit | 1,367 | 1,326 | 1,192 | 1,091 | 956.12 | 819.59 |
Selling, General & Admin | 122.81 | 110.05 | 96.18 | 65.56 | 83.72 | 78.3 |
Other Operating Expenses | 928.64 | 896.04 | 780.45 | 757.09 | 689.67 | 579.1 |
Operating Expenses | 1,101 | 1,054 | 919.27 | 844.99 | 824.95 | 699.49 |
Operating Income | 266.06 | 271.9 | 272.73 | 246.38 | 131.17 | 120.11 |
Interest Expense | -89.22 | -77.88 | -94.86 | -52.62 | -46.33 | -36.65 |
Interest & Investment Income | 8.73 | 8.73 | 1.57 | 0.91 | 0.29 | 0.3 |
Other Non Operating Income (Expenses) | -2.73 | -2.73 | -2.28 | -4.13 | -5.52 | -0.59 |
EBT Excluding Unusual Items | 182.84 | 200.02 | 177.15 | 190.54 | 79.61 | 83.17 |
Gain (Loss) on Sale of Investments | - | - | - | 1.68 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.03 | - | 0.35 |
Pretax Income | 183.64 | 200.82 | 177.15 | 192.77 | 91.95 | 85.97 |
Income Tax Expense | 52.2 | 51.07 | 46.82 | 45.88 | 26.04 | 24.26 |
Earnings From Continuing Operations | 131.44 | 149.75 | 130.33 | 146.89 | 65.92 | 61.71 |
Minority Interest in Earnings | 4.12 | 0.28 | - | - | - | - |
Net Income | 135.56 | 150.03 | 130.33 | 146.89 | 65.92 | 61.71 |
Net Income to Common | 135.56 | 150.03 | 130.33 | 146.89 | 65.92 | 61.71 |
Net Income Growth | -12.95% | 15.12% | -11.27% | 122.84% | 6.82% | 21.39% |
Shares Outstanding (Basic) | 23 | 22 | 15 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 23 | 22 | 15 | 14 | 14 | 14 |
Shares Change (YoY) | -4.24% | 44.27% | 10.11% | - | - | 0.00% |
EPS (Basic) | 6.02 | 6.86 | 8.60 | 10.67 | 4.79 | 4.48 |
EPS (Diluted) | 6.02 | 6.86 | 8.60 | 10.67 | 4.79 | 4.48 |
EPS Growth | -9.12% | -20.23% | -19.40% | 122.77% | 6.91% | 21.28% |
Free Cash Flow | -1,951 | -1,272 | -1,054 | -285.55 | -156.28 | -17.6 |
Free Cash Flow Per Share | -86.63 | -58.19 | -69.58 | -20.75 | -11.36 | -1.28 |
Gross Margin | 14.98% | 14.28% | 17.36% | 15.63% | 16.39% | 19.31% |
Operating Margin | 2.92% | 2.93% | 3.97% | 3.53% | 2.25% | 2.83% |
Profit Margin | 1.49% | 1.62% | 1.90% | 2.10% | 1.13% | 1.45% |
Free Cash Flow Margin | -21.37% | -13.69% | -15.35% | -4.09% | -2.68% | -0.41% |
EBITDA | 315.68 | 320.16 | 315.37 | 268.72 | 182.72 | 162.2 |
EBITDA Margin | 3.46% | 3.45% | 4.59% | 3.85% | 3.13% | 3.82% |
D&A For EBITDA | 49.62 | 48.26 | 42.64 | 22.34 | 51.55 | 42.09 |
EBIT | 266.06 | 271.9 | 272.73 | 246.38 | 131.17 | 120.11 |
EBIT Margin | 2.92% | 2.93% | 3.97% | 3.53% | 2.25% | 2.83% |
Effective Tax Rate | 28.42% | 25.43% | 26.43% | 23.80% | 28.31% | 28.22% |
Revenue as Reported | 9,192 | 9,358 | 6,930 | 7,064 | 5,853 | 4,272 |
Advertising Expenses | - | - | - | - | 0.85 | 0.76 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.